Elsevier’s research integrity
A Chinese paper gets rejected at Elsevier after reviewer spotted fraud. Same paper re-appears unchanged in another Elsevier journal, the editors refuse any action.
Category: COVID-19
By Leonid Schneider, on research integrity, biomedical ethics and academic publishing
For Better Science 